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Purpose
This study was conducted to evaluate the biological features of murine hepatocarcinoma
according to different tumor microenvironmental models and to determine the change in
molecular and immunologic responses after radiation.
Materials and Methods
Tumor models were established in the liver (orthotopic) and thigh (heterotopic) of male
C3H/HeN mice. Tumor growth and lung metastasis were assessed in these models. To eval-
uate the radiation effect, the tumors were irradiated with 10 Gy. Factors associated with
tumor microenvironment including vascular endothelial growth factor (VEGF), cyclooxyge-
nase-2 (COX-2), transforming growth factor beta1 (TGF-!1), CD31, and serum interleukin-
6 (IL-6) were evaluated. Tumor-infiltrating regulatory immune cells, regulatory T cells (Tregs),
and myeloid-derived suppressor cells (MDSCs) were also analyzed.
Results
A higher number of lung metastases were observed in the orthotopic tumor model than in
the heterotopic tumor model. VEGF, CD31, COX-2, and TGF-!1 expression was more promi-
nent in the orthotopic tumor model than in the heterotopic tumor model. Expression of the
angiogenic factor VEGF and key regulatory molecules (TGF-!1 and COX-2) decreased 
following radiation in the orthotopic tumor model, while the serum IL-6 level increased after
radiation. In the orthotopic tumor model, the number of both Tregs and MDSCs in the tumor
burden decreased after radiation. 
Conclusion
The orthotopic tumor model showed higher metastatic potential and more aggressive 
molecular features than the heterotopic tumor model. These findings suggest that the 
orthotopic tumor mouse model may be more reflective of the tumor microenvironment and
suitable for use in the translational research of radiation treatment.
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Introduction
The tumor microenvironment (TME) and surrounding 
adjacent normal tissues might be important modulators of
radiation therapy. The TME, a complex comprising the extra-
cellular matrix and various cell types, including carcinoma
cells, endothelial cells, fibroblasts, and immune cells, as well
as extracellular matrix molecules, is known to contribute to
the carcinoma process [1]. Recent studies have convincingly
demonstrated that the TME might be involved in regulation
of metastasis and tumor progression [2]. In this situation, a
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number of non-neoplastic cells help comprise the TME.
These non-neoplastic cells play important roles in the secre-
tion and bioavailability of pro- and anti-metastatic factors
and thus may either facilitate or suppress metastasis. Cretu
and Brooks [3] suggested an expanding array of components
that contribute to metastasis.
Tumor implantation into the thigh or dorsal skin (hetero-
topic) has been used as a standard method for establishing
murine tumor models. These types of models are helpful in
understanding the nature of cancers and therapeutic appr-
oaches; however, they are not sufficient for the investigation
of interactions of tumor cells with the surrounding microen-
vironment, including immunological responses. Therefore,
we established a syngeneic murine hepatocarcinoma model
reflecting tumor-host microenvironment and organ selectiv-
ity via orthotopic implantation. This model has several 
advantages over heterotopic models of hepatocarcinoma.
First, this model showed similar clinical settings including
tumor location, liver damage, and biochemical changes, and
supports an interaction between the tumor and host, partic-
ularly between tumor cells and microenvironment. The goal
of the current study was to evaluate the biological features
of orthotopic murine hepatocarcinoma and compare the 
molecular and immunologic responses before and after 
radiation.
Materials and Methods
1. In vivo tumorigenicity
Male C3H/HeN mice, 7-8 weeks old, were used in the cur-
rent study. Animal experiments were performed in accor-
dance with the Animal Research Committee’s Guidelines at
Yonsei University Medical College, and all facilities were 
approved by the Association for Assessment and Accredita-
tion of Laboratory Animal Care. A spontaneously developed
murine hepatocarcinoma (HCa-I) was generously provided
by Luka Milas (University of Texas M.D. Anderson Cancer
Center) and used in the current study [4]. This transplantable
murine tumor is a syngeneic, highly radioresistant tumor
with a radiation dose yielding a 50% tumor cure rate greater
than 80 Gy [5]. This model has a metastatic potential to the
lung, as well as a full host immune response, making it useful
for study of the application of immunologic findings in pre-
clinical models of cancer [6].
2. Establishment of heterotopic and orthotopic murine
tumor models
A heterotopic tumor model (Fig. 1A) was generated by 
inoculating 1!106 HCa-I cells into the muscles of the right
thighs of the mice. To evaluate changes of the tumor and nor-
mal peritumor liver by radiation, an orthotopic tumor model
was established by injection of 1!106 HCa-I cells directly into
the subcapsular parenchyma of the left lobe of the liver. To
prevent tumor cell spillage, we developed a modified surgi-
cal technique, in which a piece of surgicel (Ethicon,
Somerville, NJ) is attached on the liver injection site after 
delivery of HCa-I cells (Fig. 1B). Two weeks after tumor cell
implantation, three mice for each tumor model were ran-
domly assigned to a radiation treatment group or control
group.
3. Frequency of lung metastases associated with hetero-
topic versus orthotopic murine tumors
In HCa-I, grown in thighs, development of spontaneous
lung metastasis occurs within 5-20 days after tumor implan-
tation [7]. The mice were randomly allocated to two groups
of six animals according to the site of tumor implantation 
(orthotopic or heterotopic). The number of lung metastatic
nodules was counted for different TMEs. Mouse lungs were
taken at 6, 9, 12, and 15 days after tumor implantation and
fixed with Bouin’s solution (Fig. 1C). After 1 day, the lungs
were rinsed in water to remove excess Bouin’s solution and
the number of surface lung metastatic nodules was counted
under a light polarizing microscope (!4).
4. Radiation administration to the orthotopic murine tumor
Radiation was delivered to the abdomen as a single dose
of 10 Gy with 320 KV X-ray using the X-RAD 320 (Precision
X-ray, North Branford, CT). A lead shield containing cut-out
squares, 1.5 cm!18 cm in size was used to protect the head
and lower limbs from radiation, and the mice were aligned
for proper liver irradiation. Radiation administration was fol-
lowed by tumor inoculation 2 weeks later. Irradiated ortho-
topic tumor samples were obtained on the first and third
days after radiation. Non-irradiated orthotopic tumor sam-
ples were also obtained on the same days for comparison
with the irradiated groups. 
5. Immunohistochemical staining of tumor microenviron-
mental molecules
Immunohistochemistry was performed to assess the effect
of radiation on microenvironmental molecules in heterotopic
and orthotopic tumors, including angiogenic factors such as
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vascular endothelial growth factor (VEGF) and CD31 and
key regulatory molecules for TME such as cyclooxygenase-2
(COX-2) and transforming growth factor beta1 (TGF-!1). 
Immunohistochemical staining procedures were performed
from 4-"m-thick paraffin cut sections. Microvessel density
(MVD) was assessed using the criteria described by Weidner
[8]. Areas of highest neovascularization were identified as
regions of invasive carcinoma and the highest numbers of
discrete microvessels showed staining for CD31. 
6. Western blot analysis of tumor microenvironmental mol-
ecules 
The effects of radiation on tumor microenvironmental mol-
ecules were analyzed by Western blotting. Tumor tissue was
obtained from the heterotopic and orthotopic tumor models,
and normal peritumor liver tissue was collected from the 
orthotopic tumor model. For detection of specific proteins,
the following antibodies were used at the concentrations rec-
ommended by the manufacturers: a mouse COX-2 mono-
clonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA),
and rabbit polyclonal antibodies to TGF-!1 and VEGF
(Abcam, Cambridge, MA). After washing in TBST, the mem-
branes containing blotted proteins were incubated for 1 hour
at room temperature with either an anti-rabbit (Cell Signal-
ing Technology, Beverly, MA) or anti-mouse (Santa Cruz
Biotechnology) immunoglobulin (IgG) secondary antibody,
horseradish peroxidase conjugate. Detected proteins were
quantified by densitometry (Amersham Pharmacia Biotech,
Piscataway, NJ) after chemiluminescence detection (Fuji
Photo Film, Tokyo, Japan) using the ECL western blot detec-
tion system (Amersham Pharmacia Biotech).
7. Determination of the host response to different microen-
vironments by enzyme-linked immunosorbent assay
Serum was collected from the orthotopic and heterotopic
tumor models for measurement of serum interleukin-6 
Fig. 1.  Tumor cells were implanted in the thigh muscle (arrow) in the heterotopic tumor model (A) and at a subcapsular site
(arrow) in the liver in the orthotopic tumor model (B). The frequency of lung metastases (arrows) was determined after fix-
ation with Bouin’s solution (C) under a light microscope. The number of metastatic lung nodules was higher in the orthotopic
tumor model than in the heterotopic tumor model (D). The number of metastatic lung nodules was found to significantly
increase in the orthotopic tumor model at 6 (p=0.03), 9 (p=0.02), 12 (p=0.01), and 15 days (p=0.01) after tumor implantation.
Groups consisted of six mice each.
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(IL-6) and VEGF levels by enzyme-linked immunosorbent
assay (ELISA) using Quantikine ELISA Kits (R&D System,
Minneapolis, MN) according to the supplier’s instructions.
Blood was obtained via closed cardiac puncture using a 
22-gauge hypodermic needle and a subxyphoid approach.
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Fig. 2. (A) The orthotopic tumor model showed intense cytoplasmic immunoreactivity (!400). N, peritumor normal liver;
T, tumor tissue. (B) The immunohistochemical stains of CD31 (arrows) for heterotopic and orthotopic tumor model (!400).
(C) Vascular endothelial growth factor (VEGF) protein levels were elevated in the orthotopic tumor model (O) compared
with the heterotopic tumor model (H). CD31 expression was also higher in the orthotopic model than in the heterotopic
tumor model. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. (D) Microvessel density using CD31 increased signif-
icantly in the orthotopic tumor model (**p < 0.01). Arrows indicate the microvessels of positive CD31 immunohistochemical
staining. The number of mice was six per group.
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8. Immune response of the normal peritumor liver and
tumor by flow cytometry
For flow cytometry, the normal peritumor liver and tumor
samples were obtained, and spleen tissues were sampled as
a control. Flow cytometry was performed by FACS Calibur
and FACS Cantoll (BD Biosciences, San Jose, CA), and all 
antibodies used in this study were purchased as in our pre-
vious study [9].  
9. Statistical analysis
Results are expressed as mean±standard error. The t test
was used to determine the significance of the differences. All
tests were two-sided, and a p-value less than 0.05 indicated
statistical significance.
Results
1. Establishment of different TME animal models for
murine hepatocarcinoma
Successful tumor formation was achieved in both the het-
erotopic and orthotopic models after tumor cell inoculation.
None of the animals died during inoculation. Features of the
heterotopic and orthotopic tumor model after tumor cell 
implantation are shown in Fig. 1A and B. 
Each murine HCa-I showed rapid growth and began to
spread to the lung. In comparison of tumor behavior between
the heterotopic and orthotopic models, the average number
of metastatic lung nodules (Fig. 1C) showed a significant 
increase in the orthotopic tumor model at 6, 9, 12, and 15
days after tumor implantation (p=0.03, p=0.02, p=0.01, and
p=0.01, respectively). Fifteen days after tumor implantation,
the average numbers of lung nodules in the heterotopic and
orthotopic tumor models were 9.7±2.8 and 22.0±11.7, respec-
tively (p=0.01) (Fig. 1D). Thus, the orthotopic tumor model
showed a higher metastatic potential than the heterotopic
tumor model.   
To investigate the angiogenic factors that prominently con-
tribute to tumor stroma, VEGF expression and MVD were
compared in the different TME models. Higher VEGF 
expression was observed in the orthotopic than in the het-
erotopic tumor model as determined by immunohistochem-
ical staining. In the orthotopic tumor model, VEGF
expression was observed mainly in the tumor area, whereas
only scant VEGF expression was observed in the normal per-
titumor liver (Fig. 2A). Western blot analysis also showed
that VEGF expression was higher in the orthotopic than in
the heterotopic tumor model (Fig. 2C). 
The MVD in each experimental group was evaluated by
immunohistochemical staining for CD31 (Fig. 2B and D). Sig-
nificantly higher MVD was observed in the orthotopic than
in the heterotopic tumor model (p < 0.01), and results of
western blotting showed an increase in CD31 expression in
the orthotopic tumor model (Fig. 2D). These data indicate
that the orthotopic tumor model might have a higher
metastatic potential than the heterotopic tumor model. 
For evaluation of TGF-!1, key regulatory molecules 
involved in the TME, the expression and location of TGF-!1
protein were determined by immunohistochemistry. High
expression of TGF-!1 was observed in both the heterotopic
and the orthotopic tumor models (Fig. 3A). Interestingly, in
the orthotopic tumor model, TGF-!1 expression was more
prominent in the peripheral tumor area than in the tumor 
region. Western blot assays showed slightly higher TGF-!1
expression in the orthotopic tumor model than in the hetero-
topic tumor model (p > 0.05) (Fig. 3C).
COX-2 is also a key regulatory molecule in the TME and
plays a vital role in inhibiting apoptosis and stimulating
tumor angiogenesis. To determine the cellular localization of
active COX-2 in each tumor model, frozen sections were
stained for COX-2 (Fig. 3B). COX-2 expression was more
prominent in the orthotopic tumor area, and only slight
staining was detected in the heterotopic tumor tissue. In
western blotting analysis, the tumor showed higher COX-2
expression in the orthotopic tumor model than in the hetero-
topic tumor model (Fig. 3C). 
2. Tumor microenvironmental responses to radiation
Tumor microenvironmental responses after radiation 
exposure were evaluated according to different TME models.
Irradiated tumor samples were obtained on the third day
after radiation. The tumor compartment showed no signifi-
cant response after radiation in the heterotopic tumor model,
because prominent expression was not observed in tumor
tissue before radiation (Fig. 4A-D). The orthotopic tumor
model had far advanced and metastatic disease, therefore,
COX-2, VEGF, and TGF-!1 showed high expression before
radiation and decreased expression after radiation in tumor
tissue (Fig. 4A-C). Results of western blot analysis also
showed that COX-2 and TGF-!1 expression in tumor tissue
of the orthotopic tumor model was slightly down-regulated
after radiation except VEGF (Fig. 4D). Although we tried to
obtain information about the interaction between the tumor
and normal peritumor liver tissue, we found no significant
radiation effect due to sparse expression of host tissue.
Local radiotherapy may have an effect on systemic 
cytokine levels, which may show altered radiation responses
in different TMEs; therefore the serum IL-6 level was evalu-
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Fig. 3. (A) Orthotopic and heterotopic tumor models demonstrated intense transforming growth factor beta1 (TGF-!1) 
immunoreactivity (!400). N, peritumor normal liver; T, tumor tissue. (B) The orthotopic tumor model showed predominant
expression of cyclooxygenase-2 (COX-2) in the cytoplasm of peripheral tumor tissue (!400). (C) Western blot assays using
antibodies against TGF-!1 and COX-2 in the orthotopic (O) and heterotopic (H) tumor models showed higher TGF-!1 and
COX-2 expression in the orthotopic model than in the heterotopic tumor model. GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase.
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ated (Fig. 4E). IL-6 elevation after radiation was observed in
heterotopic and orthotopic tumor models (p=0.01 and
p=0.01, respectively), and the orthotopic tumor model
showed a significantly higher level of IL-6 than the hetero-
topic tumor model (p < 0.01). Higher serum VEGF levels
were also measured in the orthotopic model than in the het-
erotopic tumor model and the VEGF level was reduced after
irradiation in the orthotopic tumor model, but the difference
was not statistically significant (Fig. 4F). 
3. Immune cell expression after radiation 
Immune cells were analyzed according to different TME,
and we observed the elevation of frequency of regulatory T
cell (Treg) cells and increased population of CD11b+Gr-1+
myeloid-derived suppressor cells (MDSCs) in heterotopic
and orthotopic tumor models. CD11b+Gr-1+ MDSCs are
known as important other immune response regulators in
the TME. In particular, the orthotopic tumor model showed
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Fig. 4. Immunohistochemical staining with antibodies against vascular endothelial growth factor (VEGF), transforming
growth factor beta1 (TGF-!1), and cyclooxygenase-2 (COX-2) in the heterotopic and orthotopic tumor models (A-C). After
radiation, staining for VEGF, TGF-!1, and COX-2 decreased in the orthotopic tumor model (!400), while the tumor com-
partment in the heterotopic tumor model showed no significant responses after radiation (3 days after radiation). (D) These
findings were confirmed in the orthotopic tumor model by western blot assay. Expression of VEGF, TGF-!1, and COX-2 in
tumor tissues decreased after radiation, not in peritumoral normal tissue. (Continued to the next page)
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a significantly higher frequency of CD11b+Gr-1+ MDSCs than
the heterotopic tumor model [9]. 
To further investigate the frequency of immune cells in 
orthotopic tumor microenvironmental immune cells and
their response after irradiation, expression of CD4+, CD8+,
CD25+Foxp3 Treg cells, and CD11b+Gr-1+ MDSCs was exam-
ined in the orthotopic tumor bearing mouse model. The fre-
quencies of total CD4 and CD8 T cells in tumor-infiltrating
lymphocytes (TILs) are shown in the irradiated and non-
irradiated orthotopic tumor model (Fig. 5A). The number of
these cells showed a slight decrease after radiation, although
it was not statistically meaningful. The number of CD25+
Foxp3 Treg cells in the tumor was significantly decreased
after radiation (Fig. 5B), and CD11b+Gr-1+ MDSCs expression
was also significantly decreased after radiation (Fig. 5C).
Discussion
Histological examination of tumors shows the presence of
many non-epithelial cell types, which comprise the tumor
stroma. This suggests that the TME is not defined only by the
properties of the malignant cell population but rather is a
product of the interaction between tumor and non-neoplastic
tissue. In this light, heterotopic tumor implantation has a lim-
itation for use in investigation of the nature of human cancers
and their therapeutic approaches. Gao et al. [10] established
a nude mouse model of human hepatocellular carcinoma
(HCC) via orthotopic implantation of histologically intact tis-
sue. Various orthotopic HCC models have been established
in nude mice; the current study established a syngenic ortho-
topic tumor model for evaluation of microenvironmental 
alterations, including immunologic responses. This model
also represents the features of a mouse model with murine
HCC and could be an interesting tool for use in exploration
of therapeutic strategies of HCC and its microenvironmental 
effects.
According to several research studies, heterotopic and 
orthotopic tumors differ in terms of both angiogenesis and
metastasis. Morikawa et al. [11] demonstrated that implan-
tation of KM12 cells into the cecal wall (orthotopic) or a sub-
cutaneous site (heterotopic) in nude mice produces tumors
with different metastatic potentials: orthotopic tumors are
invasive and metastatic, whereas heterotopic tumors are not,
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Fig. 4. (Continued from the previous page) (E) Serum interleukin-6 (IL-6) increased after irradiation in heterotopic and orthotopic
tumor models (p=0.01 and p=0.01), and the orthotopic tumor model showed a significantly higher level of IL-6 than the het-
erotopic tumor model (p < 0.01). Increased serum VEGF levels were also measured in the orthotopic tumor model and this
level was reduced after irradiation in the orthotopic tumor model, but the difference was not significant (F). The sampling
number was six per group. N/L, normal liver of naïve mouse; N, normal peritumor liver; T, tumor; RT, radiation treatment;
GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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suggesting that different organ environments may differen-
tially influence the expression of metastasis-related genes.
Onogawa et al. [12] reported that levels of epidermal growth
factor receptor, basic fibroblast growth factor, IL-8, VEGF-C,
and VEGF-D protein were higher in orthotopic than in het-
erotopic tumors. In our current study, a more aggressive 
potential for tumor growth and lung metastasis was obse-
rved for the orthotopic model than for the heterotopic tumor
model. In addition, angiogenic factors (VEGF and CD31), key
regulatory molecules (COX-2 and TGF-!1), and serum 
cytokine (IL-6) increased in the orthotopic model compared
with that in the heterotopic tumor model. Lung metastasis
may therefore depend on changes in the TME or on tumor
cell-intrinsic genetic events. One might conclude that hetero-
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Fig. 5. Immune cell expression after radiation (n=4 mice per each group). Irradiated orthotopic tumor samples were obtained
on the third day after radiation. (A) The frequency of total CD4 and CD8 T cells in tumor-infiltrating lymphocytes are shown
in the irradiated and non-irradiated orthotopic tumor model. In tumor bearing mice (TM-bearing) mice, the frequency of
CD4 and CD8 T cells showed no significant difference after radiation. (B) The number of CD25+Foxp3 Treg cells in the tumor
was significantly decreased after radiation (p < 0.05). (C) Myeloid-derived suppressor cell CD11b+Gr-1+ expression was also
significantly decreased after radiation (p < 0.05). Treg, regulatory T cell; RT, radiation treatment; ns, not significant.
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topic tumors require a bit more time to reach the same num-
ber of lung metastases. Therefore, the heterotopic tumor
model is also valuable for investigating the metastatic
process or potential. However, there was still a lack of exper-
imental studies regarding the differences between primary
tumors and late-stage metastatic disease. 
Several clinical studies have demonstrated a direct corre-
lation of high primary tumor MVDs with increased incidence
of metastases, and tumor MVD was a significant and inde-
pendent prognostic indicator for relapse-free and overall sur-
vival of cancer patients [13]. Similarly, an elevated tumor or
serum level of IL-6 was associated with increased incidence
of metastasis in cancer patients [14,15]. In our tumor model,
angiogenic factors (VEGF and CD31) were also higher in the
orthotopic model than in the heterotopic tumor model. These
findings suggested that VEGF expression might be associ-
ated with an increased lung metastatic potential in the ortho-
topic tumor model compared with the heterotopic tumor
model. IL-6 is involved in the immune response, inflamma-
tion, and hematopoiesis. Mouthon et al. [16] found that IL-6
was increased in plasma from intestine- and liver-irradiated
mice. Chou et al. [17] reported a nonspecific increase in IL-6
levels in patients undergoing radiotherapy in a part of the
liver. IL-6 is also regarded as a major trigger of VEGF induc-
tion, and the mechanism of VEGF induction by IL-6 may be
critically involved in the progression of tumor cell growth
[18]. A significantly higher level of IL-6 was observed in our
orthotopic tumor model than the heterotopic tumor model,
and the irradiated orthotopic tumor model showed increased
serum IL-6 levels. 
Considering the TME in controlling metastasis and the
complexity of the various TME compartments, the orthotopic
animal model is a useful tool for evaluation of immunologic
findings due to its retention of a similar natural environment.
Pang et al. [19] reported that the representation of CD8+ T
cells, natural killer (NK) cells, NK-T cells, and gamma delta
(#$) T cells was significantly reduced in TILs in HCC 
patients. The CD4+ T population was substantially expanded
in TILs, and a significant increase in CD25+Foxp3 Treg cells
was observed in the tumor tissue [19]. Our previous study
demonstrated an increased population of Treg cells and 
up-regulation of inhibitory receptors by Treg cells in TILs
from heterotopic and orthotopic tumor models [9]. In addi-
tion, CD11b+Gr-1+ MDSCs also increased in both tumor mod-
els. MDSCs expressing CD11b+Gr-1+ are known to be a
negative regulator of immune responses in cancer and other
diseases. MDSCs are also associated with the induction of
Tregs in the TME, which could produce IL-10 through the
activity of the transcription factor Foxp3 [20]. Interestingly,
in our current study, orthotopic tumor models showed 
decreased CD25+Foxp3 Treg cells and CD11b+Gr-1+ MDSCs
in TIL after radiation. These findings suggest that decreased
CD11b+Gr-1+ MDSCs may enhance immune responses and
ameliorate radiotherapeutic responses. 
Although orthotopic tumor models showed a decrease of
CD25+Foxp3 Treg cells in TIL after radiation in the current
study, there are resistant CD25+Foxp3 Treg cells [21]. There-
fore, the strategy employing radiotherapy combined with 
ablation of Treg cells may improve the outcome of treatment
and prolong the survival [22]. With the development of 
molecular target therapies, the use of several drugs, antibod-
ies, or fusion proteins to reduce or eliminate human suppres-
sor cells is also currently under clinical investigation [23,24].
Thus, there is considerable support for a rationale for poten-
tial clinical trials employing multimodal TME-based thera-
pies with radiation [25]. These results highlight the potential
importance of innate immunity in antitumor responses; fur-
ther exploration of this system is needed.
Conclusion
The orthotopic tumor model demonstrated higher lung
metastatic potential and more aggressive molecular features
(VEGF, COX-2, and TGF-!1) than the heterotopic tumor
model. In the orthotopic tumor model, the angiogenic factor
VEGF, key regulatory molecules (TGF-!1 and COX-2), and
immune cells (CD25+Foxp3 Treg and CD11b+Gr-1+ cells) 
decreased after radiation. These findings suggest that an 
orthotopic tumor mouse model may be more reflective of the
TME and suitable for the investigation of radiation treat-
ment.
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